메뉴 건너뛰기




Volumn 19, Issue 1, 2011, Pages 19-26

Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome

Author keywords

Fungal infection; Itraconazole; Leukemia; Prophylaxis; Voriconazole

Indexed keywords

CLOFARABINE; CYTARABINE; FLUDARABINE; IDARUBICIN; ITRACONAZOLE; VORICONAZOLE;

EID: 78651490152     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0783-3     Document Type: Article
Times cited : (47)

References (31)
  • 1
    • 40349114639 scopus 로고    scopus 로고
    • Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: Counterpoint
    • 18319050
    • J Maertens K Buve E Anaissie 2008 Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint J Natl Compr Canc Netw 6 183 189 18319050
    • (2008) J Natl Compr Canc Netw , vol.6 , pp. 183-189
    • Maertens, J.1    Buve, K.2    Anaissie, E.3
  • 2
    • 27744541984 scopus 로고    scopus 로고
    • Role of new antifungal agents in prophylaxis of mycoses in high risk patients
    • 10.1097/01.qco.0000185984.57135.ad 16258319
    • JA van Burik 2005 Role of new antifungal agents in prophylaxis of mycoses in high risk patients Curr Opin Infect Dis 18 479 483 10.1097/01.qco. 0000185984.57135.ad 16258319
    • (2005) Curr Opin Infect Dis , vol.18 , pp. 479-483
    • Van Burik, J.A.1
  • 4
    • 0037439347 scopus 로고    scopus 로고
    • Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome
    • 1:CAS:528:DC%2BD3sXhtFGltLw%3D 10.1002/cncr.11094 12518369
    • GN Mattiuzzi E Estey I Raad F Giles J Cortes Y Shen D Kontoyiannis C Koller M Munsell M Beran H Kantarjian 2003 Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome Cancer 97 450 456 1:CAS:528: DC%2BD3sXhtFGltLw%3D 10.1002/cncr.11094 12518369
    • (2003) Cancer , vol.97 , pp. 450-456
    • Mattiuzzi, G.N.1    Estey, E.2    Raad, I.3    Giles, F.4    Cortes, J.5    Shen, Y.6    Kontoyiannis, D.7    Koller, C.8    Munsell, M.9    Beran, M.10    Kantarjian, H.11
  • 5
    • 9144238092 scopus 로고    scopus 로고
    • Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy
    • 1:CAS:528:DC%2BD2cXhs1Wrtrw%3D 10.1002/cncr.11936 14745876
    • GN Mattiuzzi H Kantarjian S Faderl J Lim D Kontoyiannis D Thomas W Wierda I Raad G Garcia-Manero X Zhou A Ferrajoli N Bekele E Estey 2004 Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy Cancer 100 581 589 1:CAS:528:DC%2BD2cXhs1Wrtrw%3D 10.1002/cncr.11936 14745876
    • (2004) Cancer , vol.100 , pp. 581-589
    • Mattiuzzi, G.N.1    Kantarjian, H.2    Faderl, S.3    Lim, J.4    Kontoyiannis, D.5    Thomas, D.6    Wierda, W.7    Raad, I.8    Garcia-Manero, G.9    Zhou, X.10    Ferrajoli, A.11    Bekele, N.12    Estey, E.13
  • 6
    • 9144253891 scopus 로고    scopus 로고
    • Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy
    • 1:CAS:528:DC%2BD2cXhs1Wrtr4%3D 10.1002/cncr.11930 14745874
    • GN Mattiuzzi H Kantarjian S O'Brien DP Kontoyiannis F Giles X Zhou J Lim BN Bekele S Faderl J Cortes S Pierce GJ Leitz I Raad E Estey 2004 Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy Cancer 100 568 573 1:CAS:528:DC%2BD2cXhs1Wrtr4%3D 10.1002/cncr.11930 14745874
    • (2004) Cancer , vol.100 , pp. 568-573
    • Mattiuzzi, G.N.1    Kantarjian, H.2    O'Brien, S.3    Kontoyiannis, D.P.4    Giles, F.5    Zhou, X.6    Lim, J.7    Bekele, B.N.8    Faderl, S.9    Cortes, J.10    Pierce, S.11    Leitz, G.J.12    Raad, I.13    Estey, E.14
  • 7
    • 0036498964 scopus 로고    scopus 로고
    • Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
    • 1:CAS:528:DC%2BD38XitlCitbg%3D 10.1086/324620 11807679
    • DW Denning P Ribaud N Milpied D Caillot R Herbrecht E Thiel A Haas M Ruhnke H Lode 2002 Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis Clin Infect Dis 34 563 571 1:CAS:528: DC%2BD38XitlCitbg%3D 10.1086/324620 11807679
    • (2002) Clin Infect Dis , vol.34 , pp. 563-571
    • Denning, D.W.1    Ribaud, P.2    Milpied, N.3    Caillot, D.4    Herbrecht, R.5    Thiel, E.6    Haas, A.7    Ruhnke, M.8    Lode, H.9
  • 11
    • 0016799829 scopus 로고
    • Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
    • 1:STN:280:DyaE28%2FhvFeisQ%3D%3D 10.2307/2529712 1100130
    • SJ Pocock R Simon 1975 Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial Biometrics 31 103 115 1:STN:280:DyaE28%2FhvFeisQ%3D%3D 10.2307/2529712 1100130
    • (1975) Biometrics , vol.31 , pp. 103-115
    • Pocock, S.J.1    Simon, R.2
  • 12
    • 12344312699 scopus 로고    scopus 로고
    • Common Terminology Criteria for Adverse Events (CTCAE) Editor (ed)^(eds) (CTCAE). DCTD, NCI, NIH, DHHS City
    • Common Terminology Criteria for Adverse Events (CTCAE) (2003). In: Editor (ed)^(eds) Book Common Terminology Criteria for Adverse Events (CTCAE). DCTD, NCI, NIH, DHHS City. http://ctep.cancer.gov
    • (2003) Book Common Terminology Criteria for Adverse Events
  • 13
    • 34547476613 scopus 로고    scopus 로고
    • Antifungal prophylaxis in chemotherapy-associated neutropenia: A retrospective, observational study
    • 10.1186/1471-2334-7-70 17605773
    • A Riedel L Choe J Inciardi C Yuen T Martin BJ Guglielmo 2007 Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study BMC Infect Dis 7 70 10.1186/1471-2334-7-70 17605773
    • (2007) BMC Infect Dis , vol.7 , pp. 70
    • Riedel, A.1    Choe, L.2    Inciardi, J.3    Yuen, C.4    Martin, T.5    Guglielmo, B.J.6
  • 16
    • 40549102818 scopus 로고    scopus 로고
    • Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity
    • 1:STN:280:DC%2BD1c7nsF2huw%3D%3D 10.1111/j.1751-553X.2007.00918.x
    • AM Whittle S Ali 2008 Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity Int J Laboratory Hematology 30 173 174 1:STN:280:DC%2BD1c7nsF2huw%3D%3D 10.1111/j.1751-553X.2007.00918.x
    • (2008) Int J Laboratory Hematology , vol.30 , pp. 173-174
    • Whittle, A.M.1    Ali, S.2
  • 17
    • 2442670429 scopus 로고    scopus 로고
    • Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients
    • 1:CAS:528:DC%2BD2cXjt1Cmu7k%3D 10.1038/sj.bmt.1704469 15034546
    • C Cordonnier S Maury C Pautas JN Bastie S Chehata S Castaigne M Kuentz S Bretagne P Ribaud 2004 Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients Bone Marrow Transplant 33 943 948 1:CAS:528:DC%2BD2cXjt1Cmu7k%3D 10.1038/sj.bmt.1704469 15034546
    • (2004) Bone Marrow Transplant , vol.33 , pp. 943-948
    • Cordonnier, C.1    Maury, S.2    Pautas, C.3    Bastie, J.N.4    Chehata, S.5    Castaigne, S.6    Kuentz, M.7    Bretagne, S.8    Ribaud, P.9
  • 18
    • 34248578429 scopus 로고    scopus 로고
    • Adverse effects of voriconazole: Analysis of the French Pharmacovigilance Database
    • 1:CAS:528:DC%2BD2sXlvFyrsb4%3D 10.1345/aph.1H671 17456542
    • C Eiden H Peyriere M Cociglio S Djezzar S Hansel JP Blayac D Hillaire-Buys 2007 Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database Ann Pharmacother 41 755 763 1:CAS:528: DC%2BD2sXlvFyrsb4%3D 10.1345/aph.1H671 17456542
    • (2007) Ann Pharmacother , vol.41 , pp. 755-763
    • Eiden, C.1    Peyriere, H.2    Cociglio, M.3    Djezzar, S.4    Hansel, S.5    Blayac, J.P.6    Hillaire-Buys, D.7
  • 19
    • 0036202635 scopus 로고    scopus 로고
    • Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: A dose escalation study
    • 1:CAS:528:DC%2BD38Xjt1ynsr8%3D 10.1177/0091270002424005 11936564
    • HM Lazarus JL Blumer S Yanovich H Schlamm A Romero 2002 Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study J Clin Pharmacol 42 395 402 1:CAS:528: DC%2BD38Xjt1ynsr8%3D 10.1177/0091270002424005 11936564
    • (2002) J Clin Pharmacol , vol.42 , pp. 395-402
    • Lazarus, H.M.1    Blumer, J.L.2    Yanovich, S.3    Schlamm, H.4    Romero, A.5
  • 20
    • 0037110465 scopus 로고    scopus 로고
    • The safety of voriconazole
    • 10.1086/343746 12410490
    • BA Potoski J Brown 2002 The safety of voriconazole Clin Infect Dis 35 1273 1275 10.1086/343746 12410490
    • (2002) Clin Infect Dis , vol.35 , pp. 1273-1275
    • Potoski, B.A.1    Brown, J.2
  • 22
    • 39449117139 scopus 로고    scopus 로고
    • Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
    • 1:CAS:528:DC%2BD1cXhvVClsbY%3D 10.1086/524669 18171251
    • A Pascual T Calandra S Bolay T Buclin J Bille O Marchetti 2008 Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes Clin Infect Dis 46 201 211 1:CAS:528:DC%2BD1cXhvVClsbY%3D 10.1086/524669 18171251
    • (2008) Clin Infect Dis , vol.46 , pp. 201-211
    • Pascual, A.1    Calandra, T.2    Bolay, S.3    Buclin, T.4    Bille, J.5    Marchetti, O.6
  • 23
    • 15544389066 scopus 로고    scopus 로고
    • Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
    • 1:CAS:528:DC%2BD2MXhsFWlsLs%3D 10.1038/sj.bmt.1704828 15654347
    • S Trifilio R Ortiz G Pennick A Verma J Pi V Stosor T Zembower J Mehta 2005 Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients Bone Marrow Transplant 35 509 513 1:CAS:528:DC%2BD2MXhsFWlsLs%3D 10.1038/sj.bmt.1704828 15654347
    • (2005) Bone Marrow Transplant , vol.35 , pp. 509-513
    • Trifilio, S.1    Ortiz, R.2    Pennick, G.3    Verma, A.4    Pi, J.5    Stosor, V.6    Zembower, T.7    Mehta, J.8
  • 24
    • 31344478761 scopus 로고    scopus 로고
    • Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities
    • 1:CAS:528:DC%2BD28XhsFejsb4%3D 10.1177/0091270005283837 16432276
    • K Tan N Brayshaw K Tomaszewski P Troke N Wood 2006 Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities J Clin Pharmacol 46 235 243 1:CAS:528:DC%2BD28XhsFejsb4%3D 10.1177/0091270005283837 16432276
    • (2006) J Clin Pharmacol , vol.46 , pp. 235-243
    • Tan, K.1    Brayshaw, N.2    Tomaszewski, K.3    Troke, P.4    Wood, N.5
  • 26
    • 33845942810 scopus 로고    scopus 로고
    • Neurological adverse events to voriconazole: Evidence for therapeutic drug monitoring
    • 1:CAS:528:DC%2BD2sXhtVOisb0%3D 17183438
    • A Imhof DJ Schaer U Schanz U Schwarz 2006 Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring Swiss Med Wkly 136 739 742 1:CAS:528:DC%2BD2sXhtVOisb0%3D 17183438
    • (2006) Swiss Med Wkly , vol.136 , pp. 739-742
    • Imhof, A.1    Schaer, D.J.2    Schanz, U.3    Schwarz, U.4
  • 27
    • 46249105803 scopus 로고    scopus 로고
    • Hallucinations during voriconazole therapy
    • 1:CAS:528:DC%2BD1cXosFekt74%3D 10.1086/588844 18491963
    • DI Zonios J Gea-Banacloche R Childs JE Bennett 2008 Hallucinations during voriconazole therapy Clin Infect Dis 47 e7 e10 1:CAS:528:DC%2BD1cXosFekt74%3D 10.1086/588844 18491963
    • (2008) Clin Infect Dis , vol.47
    • Zonios, D.I.1    Gea-Banacloche, J.2    Childs, R.3    Bennett, J.E.4
  • 28
    • 0037371527 scopus 로고    scopus 로고
    • Voriconazole: A new triazole antifungal agent
    • 1:CAS:528:DC%2BD3sXisFals7s%3D 10.1086/367933 12594645
    • LB Johnson CA Kauffman 2003 Voriconazole: a new triazole antifungal agent Clin Infect Dis 36 630 637 1:CAS:528:DC%2BD3sXisFals7s%3D 10.1086/367933 12594645
    • (2003) Clin Infect Dis , vol.36 , pp. 630-637
    • Johnson, L.B.1    Kauffman, C.A.2
  • 30
    • 1242351713 scopus 로고    scopus 로고
    • Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults
    • 10.1046/j.1365-2125.2003.01977.x 14748822
    • R Courtney D Wexler E Radwanski J Lim M Laughlin 2004 Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults Br J Clin Pharmacol 57 218 222 10.1046/j.1365-2125.2003.01977.x 14748822
    • (2004) Br J Clin Pharmacol , vol.57 , pp. 218-222
    • Courtney, R.1    Wexler, D.2    Radwanski, E.3    Lim, J.4    Laughlin, M.5
  • 31
    • 33744498620 scopus 로고    scopus 로고
    • Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients
    • 1:CAS:528:DC%2BD28XlsVOitLk%3D 10.1128/AAC.00157-06 16723557
    • PO Gubbins G Krishna A Sansone-Parsons SR Penzak L Dong M Martinho EJ Anaissie 2006 Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients Antimicrob Agents Chemother 50 1993 1999 1:CAS:528:DC%2BD28XlsVOitLk%3D 10.1128/AAC.00157-06 16723557
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 1993-1999
    • Gubbins, P.O.1    Krishna, G.2    Sansone-Parsons, A.3    Penzak, S.R.4    Dong, L.5    Martinho, M.6    Anaissie, E.J.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.